Small Business Innovation Research · Small Business Technology Transfer
CFD Research Corporation: SBIR & STTR awards
67 awards worth $32.23M to 1 companies since 1992 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
CFD Research Corporation's federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2025 | 1 | 0 | $500.0K |
| 2024 | 3 | 1 | $2.80M |
| 2023 | 2 | 2 | $4.24M |
| 2022 | 3 | 0 | $956.9K |
| 2021 | 5 | 1 | $3.19M |
| 2020 | 3 | 1 | $2.12M |
| 2019 | 5 | 1 | $2.26M |
| 2018 | 1 | 0 | $225.0K |
| 2017 | 1 | 1 | $1.72M |
| 2016 | 3 | 2 | $3.16M |
| 2014 | 1 | 0 | $224.9K |
| 2013 | 1 | 0 | $150.0K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| A high throughput alcohol screening platform (HT-ASP) incorporating cortical organoids. · topic 150 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $500.0K | 2025-05-15 |
| Controlled Release Eczema Bandage (CREB) · topic R | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.63M | 2024-09-20 |
| A Novel Mechanism of Action Natural Product for Treatment of Drug-Resistant Gonorrhea · topic NIAID | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $580.7K | 2024-04-18 |
| Advanced 3D model of the Human Cornea for Keratoconus · topic 100 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $297.2K | 2024-02-01 |
| SBIR Topic 131: Development of Bacteriophage for Treatment of Mycobacterial Infections · topic 131 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $297.7K | 2024 |
| Harmony AI: State of the Art Natural Language Processing for Genetic Engineering · topic 400 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $335.4K | 2023-09-22 |
| Harmony AI: Natural Language Processing Enabling Advanced Biomanufacturing · topic 400 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $223.9K | 2023-09-01 |
| A synergistic in vitro-in silico model of the placental barrier for predicting fetal exposure and toxicity of xenobiotic compounds · topic NICHD | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.69M | 2023-06-01 |
| Development of Patient Care Environment through Immersive Virtual Reality · topic 20 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.99M | 2023 |
| An in vitro model for screening penetration of ocular drug products · topic NEI | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2022-09-01 |
| PredictSEP: A Predictive Diagnostic Assay for Sepsis · topic 300 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $342.7K | 2022-07-18 |
| Real-Time Quantitation of Transport Across Vascular-Tissue Interfaces in Organ-On-Chip Models Using In Situ Mass Spectrometry · topic 400 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | STTR Phase I | $314.2K | 2022-04-01 |
| Multi-Scale In Vitro 3D Tissue Model of Vascularized Bone-Cartilage Interactions · topic NIAMS | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.73M | 2021-09-24 |
| Microbiome-Balancing Wraps for Managing Eczema · topic R | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $253.0K | 2021-08-01 |
| A Musculoskeletal Simulation Framework for In Silico Design and Optimization of a Soft Exosuit for Children with Muscular Dystrophy · topic 400 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $253.6K | 2021-07-15 |
| DEVELOPMENT OF PATIENT CARE ENVIRONMENT THROUGH IMMERSIVE VIRTUAL REALITY. SBIR PHASE I TOPIC 020. · topic 20 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $325.0K | 2021 |
| LABNET - RAPIDLY DEPLOYABLE AUTONOMOUS LABORATORY · topic 21 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $324.9K | 2021 |
| TO AWARD SBIR PHASE I TO CFD RESEARCH CORPORATION. · topic 95 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $299.9K | 2021 |
| ASynergysticInVitro-InSilicoModelofthePlacentalBarrierforPredictingFetalExposureand Toxicity of Xenobiotic Compounds · topic NICHD | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $251.9K | 2020-09-18 |
| Individualized Vestibular Rehabilitation for Elderly with Self-Management and Gaming Elements · topic NIDCD | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.47M | 2020-09-10 |
| A Multiscale Toolkit for Predicting Clinical Pharmacological Response of Antibody Therapeutics · topic FDA | CFD Research Corporation · Alabama | Department of Health and Human Services · Food and Drug Administration | SBIR Phase I | $168.1K | 2020-09-01 |
| A mechanism-based computational toolkit to optimize age-specific pediatric pulmonary drug delivery · topic NICHD | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $224.9K | 2020-05-18 |
| Development of Inhibitors of cANGPTL4 for Pancreatic Cancer Therapeutics · topic 102 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2019-09-19 |
| A Multiscale Simulation Toolkit for Computational Pharmacology of Trans/Intradermally Administered Compounds in Healthy and Diseased Population · topic FDA | CFD Research Corporation · Alabama | Department of Health and Human Services · Food and Drug Administration | SBIR Phase II | $999.9K | 2019-09-01 |
| A multiscale computational tool to simulate the PK of orally-administered drugs in the human GI tract · topic 400 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2019-05-01 |
| Microfluidic nasal epithelial ALI model to evaluate inhalationtoxicity caused by engineered nanomaterials · topic NIEHS | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $224.9K | 2019-05-01 |
| Microfluidic Assay for Screening Vascular Cardiotoxicity · topic NHLBI | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $283.3K | 2019-04-01 |
| Rodents Derived Synthetic Blood Brain Barrier Models for Chemical Toxicity Screening · topic NIEHS | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2019-03-15 |
| IndividualizedVestibular Rehabilitation for Elderly with Self-Management and Gaming Elements · topic NIDCD | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2018-08-01 |
| Multi Scale In Vitro D Tissue Model of Vascularized Bone Cartilage Interactions · topic NIAMS | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2017-09-19 |
| SMARTPLATE TECHNOLOGY FOR ADVANCED CELLULAR STAC M · topic NIDA | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.50M | 2017 |
| A Toolkit for Pharmacotherapy of Dermally Administered Compounds · topic FDA | CFD Research Corporation · Alabama | Department of Health and Human Services · Food and Drug Administration | SBIR Phase I | $150.0K | 2016-09-15 |
| A Predictive In Vitro Model for Screening Personalized Responses to CFTR-directed Therapeutics · topic NHLBI | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $349.9K | 2016-08-15 |
| A mechanism based computational tool to optimize pulmonary drug delivery · topic 300 | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $939.4K | 2016-07-15 |
| IGF OT IGF SBIR PHASE II TOPIC SYNVIVO TUMOR A PHYSIOLOGICAL D MODEL OF THE TUMOR MICROENVIRONMENT · topic NCI | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.50M | 2016 |
| IGF OT IGF SMARTPLATE TECHNOLOGY FOR ADVANCED CELLULAR MODELS STAC M · topic NIDA | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2016 |
| IGF::OT::IGF SBIR Phase I: SynVivo-Tumor: A Physiological 3D Model of the Tumor Microenvironment · topic NCI | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $224.9K | 2014 |
| A Diarylheptanoid Scaffold to Treat Taopathies · topic NIGMS | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $150.0K | 2013 |
| A novel physiologically realistic microfluidic in-vitro blood-brain barrier model · topic NIGMS | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.30M | 2012 |
| A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC · topic NCI | CFD Research Corporation · Alabama | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.28M | 2012 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.